PLTR is trading at $133.04 (-3.45%) as the company faces mounting pressure from UK lawmakers over its access to identifiable NHS England patient data.
- UK MPs have labeled the data access arrangement "dangerous," questioning the government's data privacy priorities and Palantir's role in handling sensitive health information.
- Shares are extending a downward trend from recent highs of $146 reached on May 4, significantly underperforming a relatively flat NASDAQ (down 0.03%).
- The company-specific controversy is acting as the primary catalyst for today's decline amid a period of low broader market volatility.